天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

ChemicalBook >> journal list >> Pulmonary Circulation >>article
Pulmonary Circulation

Pulmonary Circulation

IF: 2.2
Download PDF

Management of prostacyclin side effects in adult patients with pulmonary arterial hypertension.

Published:1 July 2017 DOI: 10.1177/2045893217719250 PMID: 28632002
Martha Kingman, Christine Archer-Chicko, Mary Bartlett, Joy Beckmann, Robin Hohsfield, Sandra Lombardi

Abstract

Therapies that target the prostacyclin pathway are considered effective, yet are complex to dose and may cause dose-limiting side effects for patients with pulmonary arterial hypertension (PAH). Careful side effect management and the ability to discern side effects from worsening disease are essential in order for patients to continue, and benefit from, prostacyclin therapy. This manuscript was developed through a collaborative effort of allied health providers with extensive experience in managing patients with PAH who are treated with medications that target the prostacyclin pathway. This article provides an overview of individual prostacyclin pathway therapies approved in the United States, side effects most commonly associated with these therapies, and practical suggestions for side effect management. Most patients will experience significant side effects on prostacyclin therapy. Creating a proactive and careful side effect management program will increase the likelihood that patients are able to stay on therapy and receive the benefits afforded by prostacyclin therapy.

Similar articles

IF:0

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine

Epilepsy and Behavior Case Reports Claudio Liguori , Francesca Izzi ,etc Published: 1 January 2018
IF:5.3

Meyler's side effects of drugs 11th edition

International Journal of Pharmaceutics P.F. D'Arcy,etc Published: 20 April 1990